OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial
Jacob P. Thyssen, Thomas Werfel, S. Barbarot, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 9
Jacob P. Thyssen, Thomas Werfel, S. Barbarot, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 9
Showing 9 citing articles:
Efficacy of Janus kinase inhibitors in immune-mediated inflammatory diseases—a systematic literature review informing the 2024 update of an international expert consensus statement
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Victoria Konzett, Josef S Smolen, Peter Nash, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Inhibidores de JAK en dermatitis atópica, nuevas perspectivas
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. 680-707
Open Access | Times Cited: 3
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. 680-707
Open Access | Times Cited: 3
[Translated article] Janus Kinase Inhibitors in Atopic Dermatitis: New Perspectives
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. T680-T707
Open Access | Times Cited: 3
M. Munera-Campos, J.M. Carrascosa
Actas Dermo-Sifiliográficas (2023) Vol. 114, Iss. 8, pp. T680-T707
Open Access | Times Cited: 3
Baricitinib treatment rapidly improves the four signs of atopic dermatitis assessed by Eczema Area and Severity Index (EASI) clinical subscores
Andreas Wollenberg, Dagmar Simon, Kanokvalai Kulthanan, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 4, pp. 695-702
Open Access | Times Cited: 3
Andreas Wollenberg, Dagmar Simon, Kanokvalai Kulthanan, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 38, Iss. 4, pp. 695-702
Open Access | Times Cited: 3
Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
Izabella Ryguła, Wojciech Pikiewicz, Konrad Kaminiów
Molecules (2023) Vol. 28, Iss. 24, pp. 8064-8064
Open Access | Times Cited: 2
Izabella Ryguła, Wojciech Pikiewicz, Konrad Kaminiów
Molecules (2023) Vol. 28, Iss. 24, pp. 8064-8064
Open Access | Times Cited: 2
Stable Response and Sustained Improvement of Itch and Sleep Symptoms in Patients with Atopic Dermatitis Treated with Lebrikizumab over 52 Weeks
Gil Yosipovitch, Peter Lio, Franz J. Legat, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 2171-2180
Open Access
Gil Yosipovitch, Peter Lio, Franz J. Legat, et al.
Dermatology and Therapy (2024) Vol. 14, Iss. 8, pp. 2171-2180
Open Access
Atopic Dermatitis-Related Problems in Daily Life, Goals of Therapy and Deciding Factors for Systemic Therapy: A Review
Liborija Lugović‐Mihić, Ema Barac, Renata Tomašević, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1455-1455
Open Access
Liborija Lugović‐Mihić, Ema Barac, Renata Tomašević, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1455-1455
Open Access
Abrocitinib effect on patient‐reported outcomes in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study
Kristian Reich, Jonathan I. Silverberg, Kim Papp, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 10, pp. 2047-2055
Open Access | Times Cited: 1
Kristian Reich, Jonathan I. Silverberg, Kim Papp, et al.
Journal of the European Academy of Dermatology and Venereology (2023) Vol. 37, Iss. 10, pp. 2047-2055
Open Access | Times Cited: 1
Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
Sarah G. Bridgeman, Anna K. Martino, Lindsay C. Strowd
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 18, pp. 2153-2159
Closed Access
Sarah G. Bridgeman, Anna K. Martino, Lindsay C. Strowd
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 18, pp. 2153-2159
Closed Access
